What happens when a new drug comes charging out of the launch gate? For Biogen Idec ($BIIB), it means a rethink of its real estate plans. Its fast-growing staff won't all fit in the new headquarters under construction in Cambridge, MA. Report
| Sponsored By: Intralinks | Publisher: October 31
The shift from fully-integrated pharmaceutical companies to the more externalized, networked model of R&D is increasingly prominent. This eBook looks into the need for secure, cloud-based platforms to share files and collaborate. Download today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!